ESTRO Annual Report 2019

4. Collaboration events European Lung Cancer Conference (ELCC) 2019 10-13 april 2019 | Geneva, Switzerland

Organised by the ESMO and IASLC with ESTRO, European Society of Thoracic Surgeons (ESTS) and the European Thoracic Oncology Platform (ETOP) as partners

The ELCC is a collaboration of the most important multidisciplinary societies that represent thoracic oncology specialists, working together to advance science, disseminate education and improve the practice of lung-cancer specialists worldwide. ELCC is now the point of reference in the field of thoracic malignancies. Since its inaugural session in 2008, it has secured its status as the premier meeting for professionals in the field. Medical oncologists, radiation oncologists, thoracic surgeons, respiratory physicians / pneumologists, interventional radiologists and pathologists all benefit from its comprehensive and stimulating programme.

European Cancer Organisation (ECCO) 2019 European cancer care across borders 12-14 September 2019 | Brussels, Belgium More than 350 leaders and stakeholders in cancer care from the fields of research, patient advocacy and public-private health-care came together at the ECCO 2019 European cancer summit. The summit theme looks to the 70:35 vision for cancer, which aims to achieve 70% average long-term survival for patients with cancer by 2035. In collaboration between member societies and the ECCO Patient Advisory Committee, it produced stimulating and illuminating sessions, and provided a platform for neglected aspects of the cancer policy debate to receive attention by: Debating leading-edge ideas in ways to improve cancer care; Trying to determine consensus resolutions for improving health-care systems;

The informative sessions explored border-busting themes such as the impact of artificial intelligence on various areas of cancer care, how to better provide cancer treatment across borders, the current status in respect of cancer patients being able to participate in clinical trials in other countries, and issues of professional specialisation and cross-border mobility of cancer experts. The summit also passed a powerful resolution regarding the elimination of cancers caused by the human papilloma virus (HPV) as a public health problem in Europe and a motion on the creation of an all-encompassing EU Cancer Mission.

Discussing and agreeing an action plan for the way forward to ensure that ideas translate into policies that will have impact on daily clinical practice.

24